HYREQ — HC Liquidating Share Price
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$8.61m
- $35.72m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -755.56% | ||
| Return on Equity | -374.52% | ||
| Operating Margin | -51.14% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3.22 | 9.78 | 15.85 | 25.23 | 35.72 | 41.33 | 60 | 133.42% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HC Liquidating, Inc., formerly HyreCar Inc., is a United States-based company. The Company has no business operations and has filed for bankruptcy.
Directors
- Grace Mellis NEC (49)
- Brian Allan PRE (58)
- Joseph Furnar CEO (40)
- Serge De Bock CFO (40)
- Megan Behrens SVP (27)
- Ken Grimes CTO (38)
- Michael Furnari OTH (36)
- Michael Root IND (60)
- Brooke Skinner Ricketts IND (40)
- Jayaprakash Vijayan IND (48)
- Last Annual
- December 31st, 2021
- Last Interim
- September 30th, 2022
- Incorporated
- November 24th, 2014
- Public Since
- June 27th, 2018
- No. of Shareholders
- 10,962
- No. of Employees
- 76
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 30,414,249
- Address
- 915 Wilshire Ave, Suite# 1950, LOS ANGELES, 90071
- Web
- https://www.hyrecar.com/
- Phone
- +1 2138396932
- Contact
- Chris Witty
- Auditors
- dbbmckennon
Upcoming Events for HYREQ
Similar to HYREQ
1399 Internet Technology Application
Pink Sheets on Nasdaq
3D Pioneer Systems
Pink Sheets on Nasdaq
9 Meters Biopharma
Pink Sheets on Nasdaq
Absolute Health and Fitness
Pink Sheets on Nasdaq
ACC Aviation Holdings
Pink Sheets on Nasdaq
FAQ
What is the HC Liquidating share price?
As of Today at 21:14 UTC, shares in HC Liquidating are trading at $0.00. This share price information is delayed by 15 minutes.
How has the HC Liquidating share price performed this year?
Shares in HC Liquidating last closed at $0.00 and the price had moved by -99.99% over the past 365 days. In terms of relative price strength the HC Liquidating share price has underperformed the S&P500 Index by -99.99% over the past year.
What are the analyst and broker recommendations for HC Liquidating?
The overall consensus recommendation for HC Liquidating is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the HC Liquidating dividend yield?
HC Liquidating does not currently pay a dividend.
Does HC Liquidating pay a dividend?
HC Liquidating does not currently pay a dividend.
When does HC Liquidating next pay dividends?
HC Liquidating does not currently pay a dividend.
How do I buy HC Liquidating shares?
To buy shares in HC Liquidating you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of HC Liquidating?
As of the previous close price of $0.00, shares in HC Liquidating had a market capitalisation of $0.00m.
Where are HC Liquidating shares listed?
Here are the trading details for HC Liquidating:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: HYREQ
What kind of share is HC Liquidating?
Based on an overall assessment of its quality, value and momentum HC Liquidating is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a HC Liquidating share price forecast for 2024?
The analyst consensus target price for shares in HC Liquidating is $4.50. That is 449999900% above the last closing price of $0.00.
Analysts covering HC Liquidating currently have a consensus Earnings Per Share (EPS) forecast of -$0.84 for the next financial year.
What is the trend in the HC Liquidating share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HC Liquidating. Over the past six months, its share price has underperformed the S&P500 Index by -9.44%.
As of the last closing price of $0.00, shares in HC Liquidating were trading -99.96% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the HC Liquidating PE Ratio?
The HC Liquidating PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of HC Liquidating?
HC Liquidating's management team is headed by:
- Grace Mellis - NEC
- Brian Allan - PRE
- Joseph Furnar - CEO
- Serge De Bock - CFO
- Megan Behrens - SVP
- Ken Grimes - CTO
- Michael Furnari - OTH
- Michael Root - IND
- Brooke Skinner Ricketts - IND
- Jayaprakash Vijayan - IND